Study Results & Research Projects

Summaries & Associations of Study Results

TR-362 4-Vinyl-1-Cyclohexene Diepoxide

Print this page Easy Link

http://ntp.niehs.nih.gov/go/8921

Target Organs and Levels of Evidence
NTP Technical Report Number 362

Produced from Chemtrack Database 09/19/01

CHEMICAL/ CAS NUMBER PEER REVIEW DATE PRIMARY USES ROUTE/EXPOSURE LEVELS STUDY LABORATORY
4-VINYL-1-CYCLOHEXENE DIEPOXIDE
106-87-6
03/13/89 ORGANIC SYNTHESIS. REACTIVE DILUENT. CHEMICAL INTERMEDIATE. (TDB) Topical R: 0, 50, 100, M: 0, 25, 50, 100 MG/ML/60 PER GROUP Battelle Columbus Laboratory
LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM):
MR: CLEAR EVIDENCE SKIN: BASAL CELL CARCINOMA 2/50 4/50 8/50; SQUAMOUS CELL CARCINOMA 0/50 33/50 36/50
FR: CLEAR EVIDENCE SKIN: BASAL CELL CARCINOMA 2/50 5/50 5/50; SQUAMOUS CELL CARCINOMA 0/50 16/50 34/50
MM: CLEAR EVIDENCE SKIN: SQUAMOUS CELL CARCINOMA 0/50 14/50 40/50 43/50
FM: CLEAR EVIDENCE SKIN: SQUAMOUS CELL CARCINOMA 0/50 6/50 37/50 43/50
OVARY: BENIGN MIXED TUMORS 0/50 0/49 11/49 6/50, GRANULOSA CELL TUMOR 0/50 0/49 5/49 10/50, LUTEOMA 1/50 0/49 0/49 0/50, OR MALIGNANT GRANULOSA CELL TUMOR 0/50 0/49 2/49 2/50 COMBINED 1/50 0/49 17/49 18/50
MAY HAVE BEEN RELATED: LUNG: ALVEOLAR/BRONCHIOLAR ADENOMA 3/50 5/50 8/50 6/50 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 1/50 4/50 3/50 1/50 COMBINED 4/50 9/50 11/50 7/50